Kenya wins vice presidency at global vaccines institute

Kenya strengthens its global health leadership footprint after securing a strategic vice presidency role at the International Vaccines Institute, signaling growing influence in vaccine research, manufacturing, and global health governance.

Kenya has secured a significant leadership role on the global health stage after being elected vice president of the International Vaccines Institute, marking a major milestone in the country’s growing influence in vaccine research and policy.

The election was confirmed on 28 April 2026 by Foreign Affairs Principal Secretary Korir Sing’oei, who said the decision was made during a high-level Global Council meeting held in Manila, Philippines.

“This morning, in Manila, Philippines, the Global Council of the International Vaccines Institute elected Kenya vice president of the institution,” Sing’oei said in a statement. He also commended Kenya’s diplomatic and scientific teams for the achievement, citing contributions from the Kenya Medical Research Institute and the Kenya BioVax Institute.

The International Vaccines Institute is an international, non-profit organization focused on improving public health through vaccine discovery, development, and distribution. Its work spans clinical trials, immunization programs, and strengthening vaccine manufacturing capacity, particularly in low- and middle-income countries.

Kenya’s election to the vice presidency places the country at the center of strategic decision-making in global immunization efforts. The role involves guiding the institute’s direction, shaping priorities, and supporting governance at the highest level.

Strategic role in vaccine governance

As vice president, Kenya will contribute to defining long-term strategies, including identifying priority diseases and regions requiring urgent attention. The position also carries oversight responsibilities to ensure policies align with global health goals and the interests of member states.

The role includes representing the institution in international engagements, strengthening partnerships, and advancing collaborative research efforts. It also involves supporting the council president and stepping in when necessary during high-level deliberations.

The appointment comes months after Kenya secured another international leadership role. In October 2025, the country was elected as one of the vice-chairpersons of the International Organization for Mediation during its inauguration in Hong Kong.

Kenya Ambassador to China Willy Bett was elected to represent the country in that position, highlighting Nairobi’s expanding diplomatic reach. The event brought together senior global leaders, including China Vice Foreign Affairs Minister Hua Chunying and Hong Kong Chief Executive John Lee.

According to Sing’oei, the appointments reflect Kenya’s growing credibility in multilateral institutions and its commitment to global cooperation.

Kenya’s leadership role at the International Vaccines Institute is expected to support its ambitions to scale up domestic vaccine production and reduce reliance on imports, positioning the country as a key player in Africa’s pharmaceutical landscape.

Tags: Health
Ericson Mangoli
About the Author

Ericson Mangoli

Senior business and economics journalist covering markets, finance and trade across East Africa.

More by this author →

Leave a Comment

Your email address will not be published. Required fields are marked *